Pandemic effect on national hospitalizations for acute hyperglycemic complications.
COVID-19
diabetes mellitus
hyperglycemia
inpatient
mortality
Journal
Proceedings (Baylor University. Medical Center)
ISSN: 0899-8280
Titre abrégé: Proc (Bayl Univ Med Cent)
Pays: United States
ID NLM: 9302033
Informations de publication
Date de publication:
2024
2024
Historique:
medline:
24
6
2024
pubmed:
24
6
2024
entrez:
24
6
2024
Statut:
epublish
Résumé
This study aimed to describe the effect of the pandemic on epidemiologic trends and disparities in outcomes for patients hospitalized with acute hyperglycemic complications (AHC). This was a retrospective study of the National Inpatient Sample (NIS) database from 2016 to 2020. The population included adults hospitalized with AHCs as a principal diagnosis using the Clinical Classifications Software Refined code. There was a decrease in the AHC hospitalization rate per 100,000 admissions for type 1 diabetes (T1D) during the pandemic (577 vs 600). However, there was an increase for type 2 diabetes (T2D) (117 vs 125). The mean age during the pandemic versus prepandemic was 34.8 ± 14.1 vs 34.7 ± 14.2 ( The pandemic had a significant impact on the hospitalization rate for both T1D and T2D.
Identifiants
pubmed: 38910828
doi: 10.1080/08998280.2024.2346391
pii: 2346391
pmc: PMC11188789
doi:
Types de publication
Journal Article
Langues
eng
Pagination
576-582Informations de copyright
Copyright © 2024 Baylor University Medical Center.
Déclaration de conflit d'intérêts
The authors report no funding or conflicts of interest.